Results

Total Results: 258 records

Showing results for "end stage renal".

181. Interventional Treatments for Acute and Chronic Pain: Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/interventional-treatments-pain/protocol
     December 17, 2020 - who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life … Medicare, defined as persons enrolled in Medicare, age >55 years, or persons with disability (including end-stage … renal disease [ESRD]), if available  Population subgroups of interest include those based on demographics … ESRD], prior substance use disorder, and psychological co-morbidities)   Patients undergoing end-of-life

182. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
     January 24, 2022 - Every 15 days until end of study period Asymptomatic Total: 18* (8.9)* HIV-: 12 (6.5) HIV+: 6 (33.3) … Hypertension: 14* (26.4) Diabetes:6* (9.4) Liver disease: 0 (0) CVD: 4* (7.5) Asthma:4* (5.7) CKD stage … Nonseroconverter: 22 (66.7) Seroconverter: 59 (59.6) Diabetes: 29 (22) Respiratory disease: 18 (13.6) Renal … the week where they reported having received their first dose of any SARS-CoV-2 vaccine or up to the end … after baseline (for unvaccinated individuals and individuals with one-dose hybrid immunity), death, or end

183. Attention Deficit Hyperactivity Disorder Medications and Risk of Serious Cardiovascular Disease in Children and Youth (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-adults_research.pdf
     November 01, 2011 - the site’s computerized data (ranging from 1986 to 2002); follow-up concluded for all sites at the end … Current use was defined as the period between the prescription start date and the end of the days of … relating ADHD use to study end points and directly adjusting for the individual covariates. … We excluded cases where there was evidence of severe underlying cardiac disease (i.e., end-stage congestive … Sickle cell disease Cystic fibrosis Cerebral Palsy Cancer HIV Organ transplant Liver failure Renal

184. Breast-Cancer-Imaging Technical-Brief (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
     October 01, 2014 - the study questions, the EPC consulted a panel of Key Informants who represent subject experts and end-users … Therefore, in the end, study questions, design, methodological approaches and/or conclusions do not … Because of their role as end-users, individuals with potential conflicts may be retained. … Axillary lymph node dissection in early- stage invasive breast cancer: is it still standard today? … magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal

185. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients With Epilepsy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_research-protocol.pdf
     February 01, 2008 - There is usually a postictal phase with confusion that accompanies the end of convulsions. … Partial Neurological: sedation, dizziness, confusion, headache, psychosis Non-Neurological: Anorexia, renal … , generalized, specific epilepsy syndrome), seizure type (new onset, chronic disease), severity or stage … of illness Severity or stage of illness (referral or primary care population) Population Events … $ at the end of a term indicates that this term has been truncated. ?

186. Disposition of Comments for Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_disposition-comments.pdf
     November 24, 2014 - More information regarding patients’ baseline characteristics, particularly renal clearance, APACHE … results section, we have added more details when available on baseline characteristics, particularly renal … realize that there was an opportunity for public comments on the study design, and that this was the stage … In the Results section we added data on baseline characteristics, particularly renal clearance, APACHE … , or antibiotic-related adverse events differ for subgroups defined by age, sex, race, ethnicity, renal

187. Safety of Vaccines Used for Routine Immunization in the United States | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/safety-vaccines/protocol
     April 06, 2020 - transplantation: official publication of the European Dialysis and Transplant Association - European Renal … Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage … renal disease population unresponsive to primary vaccination series. … Renal failure. 2015;37(7):1080-8. Zafack JG, De Serres G, Kiely M, et al. … Nervous system disorders Pregnancy, puerperium and perinatal conditions Psychiatric disorders Renal

188. Comparative Effectiveness and Safety of Analgesics for Osteoarthritis—An Update of the 2006 Report. (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-disposition-120516.pdf
     October 01, 2011 - Revised to clarify that “end of followup” results were through 12 months (page 17, line 15). … observational studies found acetaminophen associated with modest increases in blood pressure or higher risk of renal … Hypertension is the second leading cause of kidney failure or End Stage Renal Disease in the United … Effects of NSAIDs on HTN and renal function are reviewed starting on page 66, line 7. Rosa L. … At the end of the treatment period, absolute differences were statistically significant as compared

189. Translation of a C. difficile Treatment Clinical Pathway Into Machine-Readable Clinical Decision Support Artifacts Prototyped for Electronic Health Record Implementation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
     November 01, 2019 - Matter Experts and Clinical Informaticists Improved Clinical Accuracy and Usability of the Final CDS End … To that end, this AHRQ EPC methods project had two primary aims: 1. … Development of Tools and an Environment for Conducting End User L3 and L4 Artifact Testing To Assess … In the software development lifecycle, this stage of testing is often referred to as “black box” testing … implementing a computerized clinical decision support system for medication dosing for patients with renal

190. Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
     February 01, 2012 - Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma. … risk solid tumors Safety/Efficacy Study 12 4/1999- 9/2012 United States FU: Annually until end … Phase II treatment study 60 (ages 6 to 59 years) 9/1994 - End date not provided United States … weight) Systemic Lupus Erythematosus Disease Activity Index Lupus serology (ANA, dsDNA, C3, C4) Renal … Supportive care intervention 150 (75 per arm) 1/2004 – End date not reported United States

191. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
     March 01, 2012 - Based on this input, our overall assessment is that this intervention is in the lower end of the … glucose levels in urine were reported in some trials. 76 Additionally, long-term safety data on renal … Experts believe that the proposed mechanism of action of reducing blood glucose levels by preventing renal … Lilly and Amylin mutually agree to end diabetes alliance and transition exenatide responsibility to … Selected pharmaceuticals in late stage U.S. and E.U. development or registration.

192. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
     March 01, 2012 - Based on this input, our overall assessment is that this intervention is in the lower end of the … glucose levels in urine were reported in some trials. 76 Additionally, long-term safety data on renal … Experts believe that the proposed mechanism of action of reducing blood glucose levels by preventing renal … Lilly and Amylin mutually agree to end diabetes alliance and transition exenatide responsibility to … Selected pharmaceuticals in late stage U.S. and E.U. development or registration.

193. Comparative Effectiveness of Screening for Methicillin-Resistant Staphylococcus aureus (MRSA) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/mrsa-screening-2010/research-protocol
     June 02, 2011 - Anticipated subgroups include patients at high-risk for MRSA, including those with end-stage renal disease … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

194. Mrsa-Screening-2010 Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mrsa-screening-2010_research-protocol.pdf
     January 01, 2010 - Anticipated subgroups include patients at high-risk for MRSA, including those with end-stage renal … Key Informants Key Informants are the end users of research, including patients and caregivers, … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

195. Disposition of Comments for Technical Brief 27 Patient Safety (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ambulatory-safety_disposition-comments.pdf
     October 19, 2016 - Thus my 1st several readings left me w/ a feeling that it seems to almost "end before it begins." … sentences, legible orders, medication list maintenance, some decision- support successes (allergies, renal … No response needed Peer Reviewer #5 Background I thought this set the stage nicely. … I assume that keeping them anonymous at this stage is standard practice, but it would help to have a … It is AHRQ practice to keep them anonymous at the draft stage.

196. Meditation Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
     January 01, 2014 - • Was attrition <20% at the end of treatment? … One trial specified that the researchers looked for toxicities of meditation to hematologic, renal, … Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage … Change in women’s diet and body mass following intensive intervention for early-stage breast cancer … effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage

197. Hypertension-Pulmonary-Arterial Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
     April 01, 2013 - disease, thyroid disorders 5.4 Others: tumoral obstruction, fibrosing mediastinitis, chronic renal … Limited data suggest that epoprostenol and bosentan may provide a survival benefit; however, this end … At the full- text screening stage, two independent reviewers read each article to determine if it met … Of these, 1,127 were excluded at the full-text screening stage, leaving 197 articles (representing … – Consider studies of additional promising measures such as end diastolic pulmonary regurgitation

198. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
     January 01, 2012 - also increases the risk of several types of cancer including colorectal, endometrial, esophageal, renal … The phentermine plus topiramate combination is administered daily as an oral medication. 3 In late-stage … Based on this input, our overall assessment is that this intervention is in the higher end of the high-potential-impact … Based on this input, our overall assessment is that this intervention is in the lower end of the high

199. Chronic-Urinary-Retention Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
     September 01, 2014 - the study questions, the EPC consulted a panel of Key Informants who represent subject experts and end-users … Therefore, in the end, study questions, design, methodological approaches, and/or conclusions do not … Because of their role as end-users, individuals with potential conflicts may be retained. … Open Label|Primary Purpose: Treatment NCT00878176 Sacral Neuromodulation Test With Bilateral First Stage … Patients with Non- obstructive Urinary Retention: A Pilot Study Urinary Retention Procedure: First stage

200. Cad-Women-Diagnosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
     June 01, 2012 - contrast agent used during the procedure to visualize the coronary arteries may cause anaphylaxis, renal … During the topic refinement stage, we solicited input from Key Informants, representing clinicians ( … At the full-text screening stage, two independent reviewers read each article to determine if it met … At the full-text review stage, paired researchers independently reviewed the articles and indicated … Of these, 1,662 articles were excluded at the full-text screening stage.